Stockreport

Further weakness as Bio-Rad Laboratories (NYSE:BIO) drops 5.0% this week, taking three-year losses to 61% [Yahoo! Finance]

Bio-Rad Laboratories, Inc. Class B  (BIO.B) 
PDF NYSE:BIO ) shareholders know that all too well, since the share price is down considerably over three years. Regrettably, they have had to cope with a 61% drop in the sh [Read more]